Published in Ann Oncol on September 01, 1996
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol (2009) 1.61
Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative. Osteoporos Int (2008) 1.25
Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations. Fam Cancer (2004) 0.88
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Prog Lipid Res (2015) 0.84
Safety of aromatase inhibitors in the adjuvant setting. Breast Cancer Res Treat (2007) 0.80
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98. Breast Cancer Res Treat (2007) 0.80
Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group. Br J Cancer (1998) 0.76
Hormonal replacement therapy for women with a personal history of breast cancer? Ann Oncol (1996) 0.75
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. Clin Cases Miner Bone Metab (2011) 0.75
Tamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature review. BMJ Case Rep (2012) 0.75
A platelet acquired storage pool disorder associated with tamoxifen therapy. Case Rep Hematol (2012) 0.75
Laparoscopic versus open inguinal hernia repair: randomised prospective trial. Lancet (1994) 6.91
Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet (1994) 4.03
The protein Sex-lethal antagonizes the splicing factor U2AF to regulate alternative splicing of transformer pre-mRNA. Nature (1993) 3.97
Necessity of vitrectomy when optic capture is performed in children older than 5 years. J Cataract Refract Surg (2001) 3.48
Randomised controlled trial of laparoscopic versus open mesh repair for inguinal hernia: outcome and cost. BMJ (1998) 3.26
Interaction of U2AF65 RS region with pre-mRNA branch point and promotion of base pairing with U2 snRNA [corrected]. Science (1996) 3.15
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol (2000) 2.81
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Transferable EST-SSR markers for the study of polymorphism and genetic diversity in bread wheat. Mol Genet Genomics (2003) 2.55
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol (1993) 2.50
Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.47
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol (1999) 2.32
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol (1998) 2.18
Left molar approach improves laryngeal view in patients with simulated limitation of cervical movements. Acta Anaesthesiol Scand (2008) 2.17
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res (1987) 2.03
Characterization of Salmonella enterica serotype newport isolated from humans and food animals. J Clin Microbiol (2003) 2.02
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer (2004) 1.97
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet (1976) 1.92
Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol (1995) 1.87
Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer (2000) 1.85
Chlorobenzoate catabolic transposon Tn5271 is a composite class I element with flanking class II insertion sequences. Proc Natl Acad Sci U S A (1991) 1.82
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer (1973) 1.81
Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer (1989) 1.78
Aflatoxin biosynthetic pathway: elucidation by using blocked mutants of Aspergillus parasiticus. Arch Biochem Biophys (1977) 1.77
An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol (1992) 1.74
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73
An RNA-binding protein recognizes a mammalian selenocysteine insertion sequence element required for cotranslational incorporation of selenocysteine. Mol Cell Biol (1997) 1.71
Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles. Environ Health Perspect (2001) 1.65
Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil (2009) 1.62
Tamoxifen for the prevention of breast cancer. Eur J Cancer (2000) 1.62
Microsatellite-based high density linkage map in oil palm (Elaeis guineensis Jacq.). Theor Appl Genet (2005) 1.61
Introducing care pathway commissioning to primary dental care: measuring performance. Br Dent J (2011) 1.61
Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Ann Oncol (2005) 1.59
Phacoemulsification in eyes with posterior polar cataract. J Cataract Refract Surg (1999) 1.58
Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours. Clin Oncol (R Coll Radiol) (1998) 1.56
Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal? Am J Gastroenterol (1995) 1.54
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A (1982) 1.54
The association between daily mortality and ambient air particle pollution in Montreal, Quebec. 2. Cause-specific mortality. Environ Res (2001) 1.53
Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int (2006) 1.52
Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol (1999) 1.51
Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study groups (IADPSG) criteria. J Postgrad Med (2015) 1.51
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans R Soc Trop Med Hyg (2004) 1.51
Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol (1987) 1.51
Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Physiol (1996) 1.50
Phacoemulsification of white mature cataracts. J Cataract Refract Surg (1998) 1.50
Biochemical markers in human breast cancer. Lancet (1977) 1.48
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme. Eur J Cancer (1990) 1.47
c-erbB-2 expression in benign and malignant breast disease. Br J Cancer (1988) 1.47
Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46
Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood (1998) 1.46
Outcome of biphenotypic acute leukemia. Haematologica (1999) 1.46
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer (2000) 1.45
Enzymatic conversion of sterigmatocystin into aflatoxin B1 by cell-free extracts of Aspergillus parasiticus. Appl Environ Microbiol (1976) 1.45
Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours. Br Med J (1978) 1.44
Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Clin Exp Immunol (1980) 1.42
Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood (1997) 1.41
Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40
Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. Clin Chem (1996) 1.40
Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection. Trop Gastroenterol (2008) 1.39
Prevention of breast cancer. Curr Opin Oncol (1991) 1.39
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
Preventing parastomal herniation in 2014 and beyond. Colorectal Dis (2014) 1.39
Impacted Sengstaken Blakemore tube. Am J Gastroenterol (1988) 1.39
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. J Clin Oncol (1986) 1.39
Rheumatic mitral stenosis with Ebstein anomaly of tricuspid valve. Int J Cardiol (1995) 1.38
Difficult proseal laryngeal mask airway placement in a child: made easy by bougie guided technique. Paediatr Anaesth (2008) 1.38
Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl (2000) 1.38
Research and doctors. Lancet (1994) 1.37
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet (1983) 1.34
Tamoxifen and benign breast problems. Lancet (1987) 1.33
Genetic basis of pre-harvest sprouting tolerance using single-locus and two-locus QTL analyses in bread wheat. Funct Integr Genomics (2004) 1.33
Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil (2009) 1.32
Sialyloligosaccharide receptors of binding variants of polyoma virus. Virology (1983) 1.31
Monitoring of Ganga water and sediments vis-à-vis tannery pollution at Kanpur (India): a case study. Environ Monit Assess (2001) 1.30
Biosynthesis of aflatoxin. Conversion of norsolorinic acid and other hypothetical intermediates into aflatoxin B1. J Agric Food Chem (1977) 1.30
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology (1996) 1.29
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer (1995) 1.29
Rat nucleolar 7-2 RNA is homologous to mouse mitochondrial RNase mitochondrial RNA-processing RNA. J Biol Chem (1989) 1.27
Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27